KDM1A and cancer: As the first identified histone demethylase, there are more and more reports have pointed out that KDM1A is a potential drug target for the treatment of cancers (Zheng et al., 2016c; Doll et al., 2018; Lee et al., 2019; Dai et al., 2020).